Established in 2002 in the USA, NovaBone focuses on developing bone graft substitutes to meet the specialised needs of spinal and dental surgeons.
Based around developing numerous formulations and delivery systems, NovaBone’s goal is to assist in finding ways to repair osseous defects throughout the skeletal system.
NovaBone aims to provide quality, innovative products that can help in the treatment of bone-related medical conditions.
From the creation of the first bioactive synthetic bone graft offered to the orthopaedic community, to providing research into what defines the bone-forming process, NovaBone aims to serve as the go-to brand for all bone-graft related needs.
As a provider of bone graft products, NovaBone proudly partners with Device Technologies to reach the Australian and New Zealand healthcare market.